Palisade Bio, Inc. Common Stock

PALINASDAQUSD
1.84 USD
0.01 (0.27%)🟢LIVE (AS OF 01:37 PM EDT)
🟢Market: OPEN
Open?$1.83
High?$1.91
Low?$1.81
Prev. Close?$1.83
Volume?1.7M
Avg. Volume?3.8M
VWAP?$1.86
Rel. Volume?0.46x
Bid / Ask
Bid?$1.83 × 2.8K
Ask?$1.84 × 2.5K
Spread?$0.01
Midpoint?$1.84
Valuation & Ratios
Market Cap?318.0M
Shares Out?173.6M
Float?148.2M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?2.50
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Employees
14
Market Cap
318.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?23.71Strong
Quick Ratio?23.71Strong
Cash Ratio?23.60Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
2.50CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-7.0CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-19.0%WEAK
ROA?
-18.1%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$185.4M
Fundamentals ratios updated end of day